A genetic result can help explain a health condition while leaving questions about the future unanswered. Will symptoms develop? Which features might appear? How severe could they be? These are different questions, and a laboratory finding may not answer all of them.
Two terms help describe this uncertainty: penetrance and expressivity. Understanding them can make a genetics discussion clearer, especially when relatives with the same condition have different experiences.
Penetrance: whether features appear
Penetrance describes the proportion of people with a particular genetic variant who develop the associated features. When some people with that variant do not develop those features, it has reduced, or incomplete, penetrance. Some inherited cancer predispositions illustrate this: a disease-associated variant can increase cancer risk without making cancer inevitable. MedlinePlus explains reduced penetrance.
For an imaginary example, suppose 60 of 100 people with a particular variant develop a defined feature during a study. The observed penetrance for that feature would be 60% in that group. This is a teaching example, not a risk estimate for any condition. It describes a group; it does not identify which individual will develop the feature.
Expressivity: how features differ
Expressivity describes the range of features among people with a genetic condition. Relatives may differ in which organs are affected or how severe their symptoms become. Marfan syndrome provides an example: its effects can range from skeletal features to serious heart and blood vessel complications. Genetic, environmental and lifestyle influences may contribute to variation, but many remain unknown. MedlinePlus describes variable expressivity.
The distinction is useful: penetrance asks whether a defined feature appears, while expressivity asks how the condition manifests. Neither term, by itself, gives a complete forecast for one person.
A positive result has several possible meanings
The meaning of a positive genetic test depends on why testing was done. It may support a diagnosis, identify carrier status or reveal an increased chance of future disease. Interpretation also depends on the person’s medical history, family history and the type of test performed. A predictive result usually cannot establish an exact personal risk or predict the course and severity of a condition. MedlinePlus explains genetic test results.
It helps to separate three questions during a discussion: What did the laboratory find? What health significance does that finding have? What can it tell us about the future? An answer to the first question does not automatically settle the other two.
Two different kinds of uncertainty
Reduced penetrance should not be confused with a variant of uncertain significance, or VUS. With a VUS, evidence is insufficient or conflicting about whether the DNA change contributes to disease. With reduced penetrance, a disease association may be established even though some people with the variant remain unaffected. An inconclusive result cannot confirm or exclude a diagnosis. Read about uncertain and inconclusive results.
Research and clinical testing have different purposes
Research may investigate why outcomes vary, how genes work or whether a new test could be useful. Clinical genetic testing addresses questions about an individual or family and provides results that can inform medical or reproductive decisions. Both require informed consent, but participation in research does not necessarily mean receiving an individual result. MedlinePlus compares research and clinical testing.
A useful question about a new study is therefore: what has it established that can be used in care? Learning more about a biological mechanism and having a validated way to predict an individual’s future are separate achievements. A research explanation should be discussed in the context of its intended purpose and limits.
Questions that make uncertainty clearer
A genetics conversation can focus on the precise claim being made, rather than treating “positive” as a complete answer. Useful questions include:
- Does this result explain existing symptoms, indicate future risk or identify carrier status?
- Which features can this result help predict, and which remain uncertain?
- How does the family history affect its interpretation?
- Is the information being discussed established clinical evidence or a research finding?
These questions leave room for both useful knowledge and honest uncertainty. A genetic finding can matter greatly without providing a detailed timetable of a person’s future health.